Structural and Stereochemical Analysis of a Modular Polyketide Synthase Ketoreductase Domain Required for the Generation of a cis-Alkene
摘要:
The formation of an activated cis-3-cyclohexylpropenoic acid by Plm1, the first extension module of the phoslactomycin polyketide synthase, is proposed to occur through an L-3-hydroxyacyl-intermediate as a result of ketoreduction by an A-type ketoreductase (KR). Here, we demonstrate that the KR domain of Plm1 (PlmKR1) catalyzes the formation of an L-3-hydroxyacyl product. The crystal structure of PlmKR1 revealed a well-ordered active site with a nearby Trp residue characteristic of A-type KRs. Structural comparison of PlmKR1 with B-type KRs that produce D-3-hydroxyacyl intermediates revealed significant differences. The active site of cofactor-bound A-type KRs is in a catalysis-ready state, whereas cofactor-bound B-type KRs are in a precatalytic state. Furthermore, the closed lid loop in substrate-bound A-type KRs restricts active site access from all but one direction, which is proposed to control the stereochemistry of ketoreduction.
Structural and Stereochemical Analysis of a Modular Polyketide Synthase Ketoreductase Domain Required for the Generation of a cis-Alkene
摘要:
The formation of an activated cis-3-cyclohexylpropenoic acid by Plm1, the first extension module of the phoslactomycin polyketide synthase, is proposed to occur through an L-3-hydroxyacyl-intermediate as a result of ketoreduction by an A-type ketoreductase (KR). Here, we demonstrate that the KR domain of Plm1 (PlmKR1) catalyzes the formation of an L-3-hydroxyacyl product. The crystal structure of PlmKR1 revealed a well-ordered active site with a nearby Trp residue characteristic of A-type KRs. Structural comparison of PlmKR1 with B-type KRs that produce D-3-hydroxyacyl intermediates revealed significant differences. The active site of cofactor-bound A-type KRs is in a catalysis-ready state, whereas cofactor-bound B-type KRs are in a precatalytic state. Furthermore, the closed lid loop in substrate-bound A-type KRs restricts active site access from all but one direction, which is proposed to control the stereochemistry of ketoreduction.
Selective transformation of nitriles into amides and carboxylic acids by an immobilized nitrilase
作者:Norbert Klempier、Anna de Raadt、Kurt Faber、Herfried Griengl
DOI:10.1016/s0040-4039(00)92623-6
日期:1991.1
Using an immobilized nitrilase from Rhodococcus sp. mild and selective hydrolysis of nitriles can be achieved even in the presence of acid or base sensitive groups under neutral conditions. This method is applicable to a broad range of substrates as exemplified by aliphatic, alicyclic, heterocyclic and carbohydrate type nitriles.
Aldol-type Reactions of Unmasked Iodoacetic Acid with Carbonyl Compounds Promoted by Samarium Diiodide: Efficient Synthesis of Carboxylic 3-Hydroxyacids and Their Derivatives
作者:José M. Concellón、Carmen Concellón
DOI:10.1021/jo060118j
日期:2006.6.1
An easy, direct, general, and efficient samarium diiodide-mediated preparation of 3-hydroxyacids 1 in high yield by reaction of different aldehydes or ketones with commercially available iodoacetic acid is described. The application of different esterification procedures to the crude 3-hydroxyacids so obtained afforded the corresponding 3-hydroxyesters. Also, the cyclization of crude 3-hydroxycarboxylic
The reaction of trialkylvinylborate with carbon dioxide. A new method for the preparation of β-hydroxycarboxylic acids from alkenes
作者:Min-Zhi Deng、Ding-An Lu、Wei-Hua Xu
DOI:10.1039/c39850001478
日期:——
Chloromagnesium trialkylvinylborate, (R3BCHCH2)MgCl, on reaction with carbondioxide under pressure, followed by oxidation with alkaline hydrogen peroxide, gives a β-hydroxycarboxylicacid.
1,3-Dioxan-4-ones 6and 7 derived from (–)-menthone can be utilized in resolution of 3-hydroxycarboxylic acids and asymmetric synthesis of 2-substituted 3-hydroxycarboxylic acids.
[EN] INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES<br/>[FR] INHIBITEURS DE LA CRUZIPAINE ET AUTRES CYSTEINES PROTEASES
申请人:INCENTA LTD
公开号:WO2002057270A1
公开(公告)日:2002-07-25
Compounds of general formula (I) or general formula (II) wherein R1, P1, P2, Q, Y, (X)o, (W)n, (V)m, Z and U are as defined in the specification, are inhibitors of cruzipain and other cysteine protease inhibitors and are useful as therapeutic agents, for example in Chagas' disease, or for validating therapeutic target compounds.